Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

In the past several years, the otorhinolaryngology sector has had a significantimpact on social life. About 10% of the cancers that affect the populationannually concern the head and neck, and each year the guidelines evolve andchange.Emergencies of the otolaryngology sector are among the most common, withnumerous increases in hospitalizations in the ENT department (e.g., bleeding,abscesses, and dyspnoea). Interventions in the election can significantly improvepatients' quality of life and help avoid future complications.Given the importance of the medical and surgical branch of otorhinolaryngology,we want to underline the impact in social life of this important area.

anemia --- hearing loss --- auditory threshold shifts --- pure tone average --- pneumoparotid --- pneumoparotitis --- parotitis --- Stensen’s duct --- head and neck --- endomeatal approach --- cochlear implant --- posterior tympanotomy --- tinnitus --- without mastoidectomy --- quality of life assessment --- tracheoesophageal speech --- tracheo-esophageal puncture --- OSA --- pharyngoplasty --- sleep surgery --- pharynx --- dextromethorphan --- noise --- cochlea --- synapse --- eustachian tube dysfunction (ETD) --- chronic nasal obstruction --- turbinate hypertrophy --- ETDQ-7 --- susac syndrome --- multimodal imaging --- optical coherence tomography angiography --- retinal branch artery occlusion --- fluorescein angiography --- otitis media with effusion --- child --- biofilms --- ameloblastoma --- ameloblastic carcinoma --- nestin --- CD138 --- syndecan-1 --- alpha-SMA --- stemness markers --- total thyroidectomy --- recurrent laryngeal nerve paresis --- Voice Handicap Index --- speech range profile --- acute acoustic trauma --- noise induced hearing loss --- hyperbaric oxygen therapy --- Ménière’s disease --- chronic obstructive pulmonary disease --- risk factors --- case–control studies --- cohort studies

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Poly(lactic-co-glycolic acid) (PLGA) is one of the most successful polymers used for producing therapeutic devices, such as drug carriers (DC). PLGA is one of the few polymers that the Food and Drug Administration (FDA) has approved for human administration due to its biocompatibility and biodegradability. In recent years, DC produced with PLGA has gained enormous attention for its versatility in transporting different type of drugs, e.g., hydrophilic or hydrophobic small molecules, or macromolecules with a controlled drug release without modifying the physiochemical properties of the drugs. These drug delivery systems have the possibility/potential to modify their surface properties with functional groups, peptides, or other coatings to improve the interactions with biological materials. Furthermore, they present the possibility to be conjugated with specific target molecules to reach specific tissues or cells. They are also used for different therapeutic applications, such as in vaccinations, cancer treatment, neurological disorder treatment, and as anti-inflammatory agents. This book aims to focus on the recent progress of PLGA as a drug carrier and their new pharmaceutical applications.

PLGA --- nanoscaled drug delivery --- LED --- cancer --- serum stability --- reactive oxygen species --- cellular uptake --- terahertz spectroscopy --- microspheres --- drug delivery --- formulation development --- molecular mobility --- vitamin E --- tocopherol --- PLA --- core-shell nanoparticles --- controlled drug release --- BMP-2 --- PLGA nanoparticles --- Pluronic F68 --- oxaliplatin --- hydrogel --- intra-abdominal anti-adhesion barrier --- colorectal cancer --- experimental design --- fractional factorial design --- O6-methylguanine DNA methyltransferase (MGMT) protein --- glioblastoma multiforme --- smart nanocarriers --- folic acid --- verteporfin --- cisplatin --- SKOV-3 cells --- CHO-K1 cells --- electroporation --- theranostic cargo --- double emulsion approach --- NSAIDs --- polymeric film --- topical drug delivery --- trolamine salicylate --- triamcinolone acetonide --- microcrystal --- PLGA microsphere --- local delivery --- spray-drying technique --- intra-articular injection --- joint retention --- systemic exposure --- gadolinium --- drug release --- polymeric nanocarrier --- sorafenib --- theranostic nanoparticles --- PLGA-PEG --- nanoparticles --- platelet --- activation --- aggregation --- binding --- uptake --- tissue engineering --- Huntington’s disease --- siRNA --- microcarriers --- mesenchymal stromal cells --- drug delivery systems --- microfluidics --- microparticles --- BMP-2-microspheres --- hydrogel system --- 17-βestradiol release --- bone regeneration --- osteoporosis --- poly-lactide-co-glycolide --- polylactic acid --- alginate --- ophthalmic drug delivery --- dexamethasone --- PLGA-NPs --- nanomedicine --- gastrointestinal tract --- paclitaxel --- in vivo imaging --- controlled release --- risperidone --- microcapsules --- oleogels --- electron microscopy --- three-dimensional X-ray imaging --- nano-CT --- biodegradable polymers --- hydroxy-stearic acid --- PLGA nanocapsules --- magnetic resonance imaging --- photoluminescence --- magnetic targeting --- multimodal imaging --- theranostics --- silicon --- microsphere --- n/a --- Huntington's disease